Table: Towa Pharmaceutical - 6-MTH group results

TOWA PHARMACEUTICAL

13/11/2020 06:01

Nov 13 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               74.64               55.35           150.00    
                   (+34.9 pct)         (+12.6 pct)      (+35.9 pct) 
  Operating            8.78                9.22            14.30    
                   (-4.7 pct)          (+55.6 pct)      (-11.4 pct) 
  Recurring            8.73                9.74            14.80    
                   (-10.4 pct)         (+16.3 pct)      (-29.5 pct) 
  Net                  6.25                7.07            10.40    
                   (-11.5 pct)         (+14.4 pct)      (-28.3 pct) 
  EPS              127.02 yen          143.60 yen       211.34 yen  
  EPS Diluted      123.97 yen          132.82 yen                   
  Ann Div                               44.00 yen        44.00 yen  
  -Q2 div           22.00 yen           22.00 yen                   
  -Q4 div                               22.00 yen        22.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T